Overview
- 55 inspections across 51 sites are on record.
- 163 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-16.
At a glance
Inspections
55
Sites
51
Observations
163
Career since
Jul 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Xttrium Laboratories, Inc. | 16 Jun 2026 | Human Drugs | On file |
| Jilin Asymchem Pharmaceuticals Co., Ltd. | 30 Apr 2026 | Human Drugs | On file |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 24 Apr 2026 | Human Drugs | On file |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 24 Apr 2026 | Human Drugs | On file |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 24 Apr 2026 | Human Drugs | On file |
Sites inspected
Xttrium Laboratories, Inc.Mount Prospect, United States1 insp.
Jilin Asymchem Pharmaceuticals Co., Ltd.Dunhua, China1 insp.
Changchun GeneScience Pharmaceutical Co., Ltd.Changchun, China2 insp.
Changchun GeneScience Pharmaceutical Co., Ltd.Changchun, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Joohi Castelvetere4 shared
Sandra A Boyd3 shared
Eileen A Liu3 shared
Mary L Schuckmann3 shared
Gretchen L Trendel3 shared
Jacob G Lutz2 shared
Pratik S Upadhyay2 shared
Tamil Arasu2 shared
Rafeeq A Habeeb2 shared
Justin A Boyd2 shared
Full investigator report
Get the verbatim findings behind Joseph A Piechocki's 163 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site